The board of ChromoGenics advises against TopRight Nordics’ takeover bid
Statement by the board of ChromoGenics AB in relation to the takeover bid from TopRight Nordic ABThis statement is made by the Board of Directors (“the Board”) of ChromoGenics AB (“ChromoGenics” or the “Company”) in accordance with clause II.19 of the Takeover Rules for certain trading platforms (the “Takeover Rules”) applicable to companies whose shares are admitted to trading on Nasdaq First North Growth Market. Background On March 3, 2021, TopRight Nordic AB (publ) (“TopRight”) announced a public takeover bid to acquire all outstanding shares in ChromoGenics and ChormoGenics issued